-+ 0.00%
-+ 0.00%
-+ 0.00%

VERASTEM - INITIATES TREATMENT IN ALL THREE TARGET-D PHASE 2 TRIALS

路透·07/28/2026 20:01:00

登錄查看新聞詳情